Targeting the CCL2-CCR2 axis in depressive disorders
Open accessThe DOI matches its Crossref record; the references it cites are not checked yet.
Abstract
Since affective disorders are considered to be underlain by the immune system malfunction, an important role in their pathophysiology is assigned to the proinflammatory mediators. Recently, chemokines, the group of chemotactic cytokines, have become a focus for basic and clinical scientists in the context of the development and treatment of brain diseases. Among them, chemokine CCL2 and its main receptor CCR2 have become candidate mediators of abnormal brain-immune system dialogue in depression. Besides the chemotactic activity, the CCL2-CCR2 axis is involved in various neurobiological processes, neurogenesis, neurotransmission, neuroinflammation, neurodegeneration, as well as neuroregeneration. Given the range of immunomodulatory possibilities that the CCL2-CCR2 pair can exert on the nervous system, its proinflammatory properties were initially thought to be a major contributor to the development of depressive disorders. However, further research suggests that the malfunctions of the nervous system are rather associated with impaired homeostatic properties manifested by the CCL2-CCR2 dyad dysfunctions. This review aims to present literature data on the action of the CCL2-CCR2 axis in the central nervous system under physiological and pathological conditions, as well as the contribution of this ligand-receptor system to the processes underlying affective disorders. Additionally, this article draws attention to the importance of the CCL2-CRR2 pathway as a potential pharmacological target with antidepressant potential.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“It might as likely contribute to neurodegeneration and neuroinflammation as to neuroregeneration and neurotransmission [181].”
From Selected biomarkers of depression: what are the effects of cytokines and inflammation (2022) · cites this paper as [181]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
The citation lists are queued
They are fetched later and appear here then.
References 85 · Cited by 47
Metadata
- Authors
- Curzytek, K., & Leśkiewicz, M.
- Affiliations
- Maj Institute of Pharmacology (PL)
- Corresponding author
- Curzytek, Katarzyna
- Venue
- Pharmacological Reports
- Published
- 2021-05-24
- Volume
- 73
- Issue
- 4
- Pages
- 1052-1062
- ISSN
- 1734-1140 (ISSN-L)
- 2299-5684
- PMC
- PMC8142870
- OpenAlex
- W3165273974
- Cited by
- 47
- References
- 85
- Citations by year
- 2026: 4 · 2025: 11 · 2024: 14 · 2023: 8 · 2022: 9 · 2021: 1
- FWCI
- 0.75
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Pharmacological Reports (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- Statutory Funds of the Department of Experimental Neuroendocrinology, Maj Institute of Pharmacology
- Topics
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- MCP-1, CCR2, chemokines, depression, depressive disorders, neuroinflammation, pro-inflammatory mediators, antidepressant targets, chemokine receptors, neurogenesis, neurotransmission, nerve regeneration
- MeSH terms
- Animals, Antidepressive Agents, Central Nervous System, Depressive Disorder, Humans, Signal Transduction, Chemokine CCL2, Receptors, CCR2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Targeting the CCL2-CCR2 axis in depressive disorders. https://app.cochat.ai/papers/10.1007/s43440-021-00280-w
- The paper
- Curzytek, K., & Leśkiewicz, M. (2021). Targeting the CCL2-CCR2 axis in depressive disorders. Pharmacological Reports. https://doi.org/10.1007/s43440-021-00280-w
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.